Impact of maternal obesity on fetal cardiac screening: which follow-up strategy is cost-effective?
To perform a cost-effectiveness analysis of incomplete fetal cardiac screening with different follow-up strategies for non-obese and obese women. Three decision-analytic models-one each for non-obese, obese, and Class III obese women-were developed to compare follow-up (f/u) strategies for initial suboptimal fetal cardiac screening. Five strategies studied were: (a) no f/u ultrasound (US) but direct to fetal echocardiography (FE), (b) 1 f/u US and then FE if cardiac views were still suboptimal, (c) up to 2 f/u US and then FE if cardiac views were still suboptimal, (d) 1 f/u US and no FE, and (e) up to 2 f/u US and no FE. The models identified fetuses with major CHD in a theoretical cohort of 4,000,000 births. Outcomes related to neonatal mortality and neuro-developmental disability were calculated. A cost-effectiveness threshold was set at $100,000 per quality-adjusted life years (QALY). Base case, sensitivity analysis, and Monte Carlo simulation were performed. In our base-case models for all BMI groups, no f/u US and direct referral to FE led to the best outcomes, detecting 7%, 25%, and 82% more CHD for non-obese, obese, and Class III obese respectively, compared to the baseline strategy, 1 f/u US and no FE. However, no f/u US and direct referral to FE was over the $100,000/QALY threshold and therefore not cost-effective. The cost-effective strategy for all BMI groups was up to 1 f/u US and no FE. Both 2 f/u US and no FE and 2 f/u and FE were dominated (more costly and less effective), while 1 f/u and FE was over the cost-effectiveness threshold. 1 f/u US and no FE was the optimal strategy in 97%, 93%, and 86% of trials in Monte Carlo for the non-obese, obese, and Class III obese models respectively. For both non-obese and obese women, the optimal CHD screening strategy is no further US and immediate referral to FE; however, this strategy is not cost-effective. Considering costs, 1 f/u US and no FE is the preferred strategy. For both obese and non-obese women, Monte Carlo simulations were very clear that 1 f/u US and no FE was the optimal strategy. Both non-obese and obese women should be offered up to 1 f/u ultrasounds if fetal cardiac screening is not completed. This article is protected by copyright. All rights reserved.